AEVI GENOMIC MEDICINE INC's ticker is GNMX and the CUSIP is 00835P105. A total of 80 filers reported holding AEVI GENOMIC MEDICINE INC in Q4 2016. The put-call ratio across all filers is 0.06 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $0 | -100.0% | 100 | -94.0% | 0.00% | – |
| Q4 2018 | $1,000 | -75.0% | 1,671 | -58.1% | 0.00% | – |
| Q3 2018 | $4,000 | – | 3,991 | +18904.8% | 0.00% | – |
| Q2 2018 | $0 | – | 21 | -27.6% | 0.00% | – |
| Q4 2017 | $0 | – | 29 | -87.3% | 0.00% | – |
| Q3 2017 | $0 | – | 229 | -23.7% | 0.00% | – |
| Q1 2017 | $0 | -100.0% | 300 | -57.6% | 0.00% | – |
| Q4 2016 | $3,000 | – | 708 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|